After graduating from a Master in Drug Sciences, specializing in Biotherapies and Advanced Medicinal Products, from the University of Nantes, Julie Vignau joined VibioSphen as a PhD Student in 2021.
She has experience in both academic laboratories, in Nantes and in Liverpool, and in a biotechnology company, in the Netherlands.
She acquired skills in cell culture, immunology, cancerology, and inflammation. Indeed, she has worked on preclinical development of different type of biotherapeutics, such as vaccines, antibodies, or small molecules, targeting tumour cells, bacteria, and inflammatory diseases.

PhD student